BioCryst Pharmaceuticals
BCRX
#4879
Rank
A$2.87 B
Marketcap
A$11.16
Share price
0.79%
Change (1 day)
0.69%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): A-$1.87

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$2.09. In 2022 the company made an earnings per share (EPS) of A-$1.93 a decrease over its 2021 EPS that were of A-$1.49.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1.87-2.97%
2022A-$1.9329.13%
2021A-$1.49-4.63%
2020A-$1.5710.2%
2019A-$1.420%
2018A-$1.4225.64%
2017A-$1.134%
2016A-$1.0927.12%
2015A-$0.86-13.24%
2014A-$0.9923.64%
2013A-$0.80-30.38%
2012A-$1.15-37.3%
2011A-$1.8365.79%
2010A-$1.10117.14%
2009A-$0.51-46.15%
2008A-$0.94-26.97%
2007A-$1.29-40.67%
2006A-$2.1848.51%
2005A-$1.471%
2004A-$1.4538.89%
2003A-$1.04-25%
2002A-$1.39231.03%
2001A-$0.42-56.72%
2000A-$0.9791.43%
1999A-$0.512.94%
1998A-$0.49-55.84%
1997A-$1.1211.59%
1996A-$1.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
A-$4.50 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.17-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A-$3.82 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A-$0.29-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A-$2.21 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.31 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A-$0.64-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$4.61 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.99 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA